Silvia Sabine Jurisson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Silvia Sabine Jurisson has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
Alan R. Ketring
University of Missouri Research Reactor Center (MURR), Columbia, MO, 65211, USA
10 shared publicationsCathy S. Cutler
Collider Accelerator Department , Brookhaven National Laboratory , Upton , NY , USA
10 shared publications- Heather M. Hennkens
Department of Chemistry , University of Missouri , Columbia , 65211 , MO , USA
10 shared publications Charles L. Barnes
Department of Chemistry, University of Missouri, Columbia, MO 65211, USA.
9 shared publicationsTimothy J. Hoffman
Research Service, Harry S. Truman Memorial Veterans’ Hospital, Columbia, Missouri 65201, United States
8 shared publicationsFabio Gallazzi
Department of Chemistry, University of Missouri, Columbia, MO 65211, USA; Molecular Interactions Core, University of Missouri, Columbia, MO 65211, USA
7 shared publications
Latest Publications
- Open Access
- 1 February 2023
- Published by Office of Scientific and Technical Information (OSTI)
Production and Separations for High Specific Activity 186Re, 189Re and 47Sc for Research and Clinical Applications: effective design of targets and recycling of targets and radioisotope separation
This grant involved three objectives for producing high specific activity radionuclides using reactor and accelerator technologies that would find use in medical, industrial and research applications. There was a strong emphasis in all projects to develop and train staff and students in all aspects of targetry, reactor and accelerator production, separation of radionuclides from enriched target material, and evaluating the specific activity of the product radionuclides. An additional objective was training of students (undergraduate, graduate, postdoctoral) in all aspects of radiochemistry.
- 1 February 2023
- Published by Office of Scientific and Technical Information (OSTI)
Open AccessProduction and Separations for High Specific Activity 186Re, 189Re and 47Sc for Research and Clinical Applications: effective design of targets and recycling of targets and radioisotope separation
This grant involved three objectives for producing high specific activity radionuclides using reactor and accelerator technologies that would find use in medical, industrial and research applications. There was a strong emphasis in all projects to develop and train staff and students in all aspects of targetry, reactor and accelerator production, separation of radionuclides from enriched target material, and evaluating the specific activity of the product radionuclides. An additional objective was training of students (undergraduate, graduate, postdoctoral) in all aspects of radiochemistry.
- 21 April 2022
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 110 (6-9) , 739-749
Evaluation of 186WS2 target material for production of high specific activity 186Re via proton irradiation: separation, radiolabeling and recovery/recycling
Enriched tungsten disulfide (186WS2) was evaluated at increasing proton beam currents (20–50 μA) and times (up to 4 h) on a GE PETtrace cyclotron for production of high specific activity (HSA) 186Re. The HSA 186Re was separated from the irradiated target as [186Re][ReO4]– by a liquid–liquid extraction method and radiolabeled with a new N2S2 ligand (222-MAMA-N-ethylpropionate). The enriched 186W was recovered from the extraction process, analyzed for purity and enrichment, and converted back to the disulfide (186WS2). The results demonstrate that the 186WS2 is an easily pressed target material that can withstand relatively high currents and can be readily recovered and recycled. The 186Re produced was isolated in high specific activity and readily formed the radiotracers [186Re][ReO(222-MAMA-N-ethylpropionate)] and [186Re][Re(CO)3(OH2)3] +.
- 21 April 2022
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 110 (6-9) , 739-749
Evaluation of 186WS2 target material for production of high specific activity 186Re via proton irradiation: separation, radiolabeling and recovery/recycling
Enriched tungsten disulfide (186WS2) was evaluated at increasing proton beam currents (20–50 μA) and times (up to 4 h) on a GE PETtrace cyclotron for production of high specific activity (HSA) 186Re. The HSA 186Re was separated from the irradiated target as [186Re][ReO4]– by a liquid–liquid extraction method and radiolabeled with a new N2S2 ligand (222-MAMA-N-ethylpropionate). The enriched 186W was recovered from the extraction process, analyzed for purity and enrichment, and converted back to the disulfide (186WS2). The results demonstrate that the 186WS2 is an easily pressed target material that can withstand relatively high currents and can be readily recovered and recycled. The 186Re produced was isolated in high specific activity and readily formed the radiotracers [186Re][ReO(222-MAMA-N-ethylpropionate)] and [186Re][Re(CO)3(OH2)3] +.
- 4 October 2021
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 60 (20) , 15223-15232
A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XXSb(III) Complex, and Selective Chelation of Radioantimony (119Sb) from Its Sn Target
The therapeutic potential of the Meitner-Auger- and conversion-electron emitting radionuclide 119Sb remains unexplored because of the difficulty of incorporating it into biologically targeted compounds. To address this challenge, we report the development of 119Sb production from electroplated tin cyclotron targets and its complexation by a novel trithiol chelate. The chelation reaction occurs in harsh solvent conditions even in the presence of large quantities of tin, which are necessary for production on small, low energy (16 MeV) cyclotrons. The 119Sb-trithiol complex has high stability and can be purified by HPLC. The third generation trithiol chelate and the analogous stable natSb-trithiol compound were synthesized and characterized, including by single-crystal X-ray diffraction analyses.
- 4 October 2021
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 60 (20) , 15223-15232
A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XXSb(III) Complex, and Selective Chelation of Radioantimony (119Sb) from Its Sn Target
The therapeutic potential of the Meitner-Auger- and conversion-electron emitting radionuclide 119Sb remains unexplored because of the difficulty of incorporating it into biologically targeted compounds. To address this challenge, we report the development of 119Sb production from electroplated tin cyclotron targets and its complexation by a novel trithiol chelate. The chelation reaction occurs in harsh solvent conditions even in the presence of large quantities of tin, which are necessary for production on small, low energy (16 MeV) cyclotrons. The 119Sb-trithiol complex has high stability and can be purified by HPLC. The third generation trithiol chelate and the analogous stable natSb-trithiol compound were synthesized and characterized, including by single-crystal X-ray diffraction analyses.
- 1 October 2021
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 176, 109847
Recovery, recycling and re-irradiation of enriched 104Ru metal targets for cost effective production of 105Rh
- 1 October 2021
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 176, 109847
Recovery, recycling and re-irradiation of enriched 104Ru metal targets for cost effective production of 105Rh
- 10 January 2021
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 32 (7) , 1364-1373
A New, Second Generation Trithiol Bifunctional Chelate for 72,77As: Trithiol(b)-(Ser)2-RM2
Trithiol chelates are suitable for labeling radioarsenic (72As: 2.49 MeV β+, 26 h; 77As: 0.683 MeV β–, 38.8 h) to form potential theranostic radiopharmaceuticals for positron emission tomography (PET) imaging and therapy. A trithiol(b)-(Ser)2-RM2 bioconjugate and its arsenic complex were synthesized and characterized. The trithiol(b)-(Ser)2-RM2 bioconjugate was radiolabeled with no-carrier-added 77As in over 95% radiochemical yield and was stable for over 48 h, and in vitro IC50 cell binding studies of [77As]As-trithiol(b)-(Ser)2-RM2 in PC-3 cells demonstrated high affinity for the gastrin-releasing peptide (GRP) receptor (low nanomolar range). Limited biodistribution studies in normal mice were performed with HPLC purified 77As-trithiol(b)-(Ser)2-RM2 demonstrating both pancreatic uptake and hepatobiliary clearance.
- 10 January 2021
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 32 (7) , 1364-1373
A New, Second Generation Trithiol Bifunctional Chelate for 72,77As: Trithiol(b)-(Ser)2-RM2
Trithiol chelates are suitable for labeling radioarsenic (72As: 2.49 MeV β+, 26 h; 77As: 0.683 MeV β–, 38.8 h) to form potential theranostic radiopharmaceuticals for positron emission tomography (PET) imaging and therapy. A trithiol(b)-(Ser)2-RM2 bioconjugate and its arsenic complex were synthesized and characterized. The trithiol(b)-(Ser)2-RM2 bioconjugate was radiolabeled with no-carrier-added 77As in over 95% radiochemical yield and was stable for over 48 h, and in vitro IC50 cell binding studies of [77As]As-trithiol(b)-(Ser)2-RM2 in PC-3 cells demonstrated high affinity for the gastrin-releasing peptide (GRP) receptor (low nanomolar range). Limited biodistribution studies in normal mice were performed with HPLC purified 77As-trithiol(b)-(Ser)2-RM2 demonstrating both pancreatic uptake and hepatobiliary clearance.
- 17 October 2019
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 108 (6)
Frontmatter
Article Frontmatter was published on June 1, 2020 in the journal Radiochimica Acta (volume 108, issue 6).
- 17 October 2019
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 108 (6)
Frontmatter
Article Frontmatter was published on June 1, 2020 in the journal Radiochimica Acta (volume 108, issue 6).
- 21 September 2019
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 108 (5)
Frontmatter
Article Frontmatter was published on May 1, 2020 in the journal Radiochimica Acta (volume 108, issue 5).
- 21 September 2019
- Published by Walter de Gruyter GmbH in Radiochimica Acta
- Vol. 108 (5)
Frontmatter
Article Frontmatter was published on May 1, 2020 in the journal Radiochimica Acta (volume 108, issue 5).
- 8 August 2019
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 48 (34) , 12943-12955
Steric influence of salicylaldehyde-based Schiff base ligands on the formation oftrans-[Re(PR3)2(Schiff base)]+complexes
The steric effects of backbone groups on the synthesis and stability oftrans-[Re(PR3)2(Schiff base)]+compounds were assessed using NMR, HPLC, electrochemistry and single crystal X-ray diffraction.
- 8 August 2019
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 48 (34) , 12943-12955
Steric influence of salicylaldehyde-based Schiff base ligands on the formation oftrans-[Re(PR3)2(Schiff base)]+complexes
The steric effects of backbone groups on the synthesis and stability oftrans-[Re(PR3)2(Schiff base)]+compounds were assessed using NMR, HPLC, electrochemistry and single crystal X-ray diffraction.
- 1 February 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (3) , 492-501
Synthesis and evaluation of Re/99mTc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent
- 1 February 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (3) , 492-501
Synthesis and evaluation of Re/99mTc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent